Fixed pharmaceutical group recalled all capsule products

Global online B2B marketplace : http://www.bytrade.com

April 23,, our reporter through various channels, confirmed that fixed pharmaceutical are nationwide organization recalled products all capsule.

Had planned to 20 April arrived in hefei, and clearly for the 67th annual national medicines correction of the chairman XiuLaiGui pharmaceutical trade fair temporary fail, make more road waiting in hefei reporter flapping empty air. Fixed news spokesman LiJia revealed: about the company are trying their best to the drug recall organization, so will miss the enterprise top drug intersect.

Guangzhou confirmed a pharmacy, fixed telephone inform all capsule pharmaceutical products stop selling, drugstore is working with the work well to seal, which, he said, is "the administration's request of the recall". However, the administration's audit branch of jilin province on April 23, said: "not know relevant circumstances, auditing branches sealed and does not participate in the recall work."

April 21,, the health ministry issued a medical institutions at various levels required with the drug agency, recalled all capsule chromium overweight batches of the drug.

In 2010, fixed pharmaceutical sales income is 17.1 billion yuan, in 2011 the company has also said that could be close to 30 billion yuan. Have institutions had evaluated, fixed pharmaceutical has 13 varieties single product sales more than 100 million yuan, including starr extends and so on eight capsule products and lung ning and other varieties.

The "poison capsule" event of the recall case, the far pharmaceutical dandong city two batches of bezoar metronidazole capsule production 5000 boxes of, the recall of 2757 boxes.

In October 2010, the tai chi group (7.24, 0.11, 1.50%) QuMei recalls perhaps more reference value. In the first half of 2010, before QuMei recalled, total sales income is 122 million yuan. And tai chi recalled QuMei, including medicine loss, recall cost to bring the actual loss of about 101 million yuan, almost half a year to the product sales.

Because modified pharmaceutical aren't capsule product actual sales, therefore are still unable to estimate the actual loss caused by the.

A pharmaceutical people therefore said, in sales data not public, or according to the sales of nearly 50% of the estimated proportion recalled the loss. In 2010, fixed the star products of the pharmaceutical starr comfortable capsule sales in 800 million yuan of above, once the implementation recall, involving market value could reach 400 million yuan of above. And the correction of capsule pharmaceutical drugs of 67, the total value of the recall may will be a astronomical figures.